Qube Research & Technologies (QRT)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Buy |
18,085
+13,035
| +258% | +$1.48M | ﹤0.01% | 1573 |
|
|
2025
Q1 | $531K | Buy |
+5,050
| New | +$531K | ﹤0.01% | 1953 |
|
|
2024
Q2 | – | Sell |
-79
| Closed | -$5.78K | – | 3854 |
|
|
2024
Q1 | $5.78K | Sell |
79
-14,580
| -99% | -$1.07M | ﹤0.01% | 3354 |
|
|
2023
Q4 | $1.05M | Sell |
14,659
-25,595
| -64% | -$1.83M | ﹤0.01% | 1614 |
|
|
2023
Q3 | $2.41M | Buy |
40,254
+24,610
| +157% | +$1.47M | 0.01% | 1032 |
|
|
2023
Q2 | $1.13M | Buy |
15,644
+10,396
| +198% | +$750K | ﹤0.01% | 1185 |
|
|
2023
Q1 | $386K | Buy |
5,248
+1,481
| +39% | +$109K | ﹤0.01% | 1592 |
|
|
2022
Q4 | $252K | Sell |
3,767
-9,092
| -71% | -$607K | ﹤0.01% | 1647 |
|
|
2022
Q3 | $691K | Sell |
12,859
-20,597
| -62% | -$1.11M | ﹤0.01% | 1293 |
|
|
2022
Q2 | $1.86M | Buy |
33,456
+21,499
| +180% | +$1.2M | 0.01% | 835 |
|
|
2022
Q1 | $839K | Buy |
+11,957
| New | +$839K | 0.01% | 1237 |
|
|
2020
Q3 | – | Sell |
-24,795
| Closed | -$1.73M | – | 1932 |
|
|
2020
Q2 | $1.73M | Buy |
+24,795
| New | +$1.73M | 0.03% | 696 |
|